Choreo, LLC Gilead Sciences, Inc. Transaction History

Choreo, LLC

$5.94 Billion
Q2 2024

A detailed history of Choreo, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Choreo, LLC holds 45,501 shares of GILD stock, worth $4.02 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

45,501

Previous 9,963 356.7%

Holding current value

$4.02 Million

Previous $729,000 328.12%

% of portfolio

0.05%

Previous 0.02%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$63.15 - $72.88 $2.24 Million - $2.59 Million	35,538 Added 356.7%	45,501 $3.12 Million
Q1 2024 May 02, 2024	BUY	$71.58 - $87.29 $129,989 - $158,518	1,816 Added 22.29%	9,963 $729,000
Q4 2023 Feb 05, 2024	BUY	$73.27 - $83.09 $208,379 - $236,307	2,844 Added 53.63%	8,147 $659,000
Q3 2023 Nov 08, 2023	BUY	$73.94 - $80.67 $10,499 - $11,455	142 Added 2.75%	5,303 $397,000
Q2 2023 Aug 04, 2023	SELL	$76.01 - $86.7 $5,472 - $6,242	-72 Reduced 1.38%	5,161 $397,000
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $404,563 - $460,922	5,233 New	5,233 $434,000
Q4 2018 Jun 04, 2020	SELL	$60.54 - $79.0 $213,524 - $278,633	-3,527 Closed	0 $0
Q3 2018 Jun 04, 2020	SELL	$71.28 - $78.92 $47,329 - $52,402	-664 Reduced 15.84%	3,527 $272,000
Q2 2018 Jun 04, 2020	SELL	$64.88 - $75.68 $129,435 - $150,981	-1,995 Reduced 32.25%	4,191 $297,000
Q1 2018 Jun 04, 2020	BUY	$72.84 - $88.8 $32,850 - $40,048	451 Added 7.86%	6,186 $466,000
Q4 2017 Jun 04, 2020	BUY	$71.15 - $83.52 $11,312 - $13,279	159 Added 2.85%	5,735 $411,000
Q3 2017 Jun 04, 2020	BUY	$72.11 - $85.47 $79,032 - $93,675	1,096 Added 24.46%	5,576 $452,000
Q2 2017 Jun 04, 2020	SELL	N/A	-941 Reduced 17.36%	4,480 $317,000
Q1 2017 Jun 04, 2020	BUY	N/A	748 Added 16.01%	5,421 $368,000
Q4 2016 Jun 04, 2020	SELL	N/A	-3,849 Reduced 45.17%	4,673 $335,000
Q3 2016 Jun 04, 2020	SELL	N/A	-413 Reduced 4.62%	8,522 $674,000
Q2 2016 Jun 04, 2020	BUY	N/A	2,195 Added 32.57%	8,935 $745,000
Q1 2016 Jun 04, 2020	BUY	N/A	3,498 Added 107.9%	6,740 $619,000
Q4 2015 Jun 04, 2020	BUY	N/A	480 Added 17.38%	3,242 $328,000
Q3 2015 Jun 04, 2020	BUY	N/A	522 Added 23.3%	2,762 $271,000
Q2 2015 Jun 04, 2020	BUY	N/A	198 Added 9.7%	2,240 $262,000
Q1 2015 Jun 04, 2020	BUY	N/A	2,042 New	2,042 $200,000
Q4 2014 Jun 04, 2020	SELL	N/A	-2,611 Closed	0 $0
Q3 2014 Jun 04, 2020	BUY	N/A	2,611 New	2,611 $278,000
Q2 2014 Jun 04, 2020	SELL	N/A	-4,533 Closed	0 $0
Q1 2014 Jun 04, 2020	BUY	N/A	4,533	4,533 $321,000

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Choreo, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Choreo, LLC with notifications on news.

Account